  In light of the NIMH's Research Domain Criteria (RDoC), the advent of
functional neuroimaging, novel technologies and methods provide new
opportunities to develop precise and personalized prognosis and diagnosis of
mental disorders. Machine learning (ML) and artificial intelligence (AI)
technologies are playing an increasingly critical role in the new era of
precision psychiatry. Combining ML/AI with neuromodulation technologies can
potentially provide explainable solutions in clinical practice and effective
therapeutic treatment. Advanced wearable and mobile technologies also call for
the new role of ML/AI for digital phenotyping in mobile mental health. In this
review, we provide a comprehensive review of the ML methodologies and
applications by combining neuroimaging, neuromodulation, and advanced mobile
technologies in psychiatry practice. Additionally, we review the role of ML in
molecular phenotyping and cross-species biomarker identification in precision
psychiatry. We further discuss explainable AI (XAI) and causality testing in a
closed-human-in-the-loop manner, and highlight the ML potential in multimedia
information extraction and multimodal data fusion. Finally, we discuss
conceptual and practical challenges in precision psychiatry and highlight ML
opportunities in future research.
